We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
(-0.91%)
Cap. Flow
+$8.92M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$92.9M |
| 2 |
Amazon
AMZN
|
+$62.6M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$46.3M |
| 4 |
VMEO
Vimeo
VMEO
|
+$33.1M |
| 5 |
UnitedHealth
UNH
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$49.9M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$43.5M |
| 3 |
Humana
HUM
|
+$36.6M |
| 4 |
Vipshop
VIPS
|
+$35.6M |
| 5 |
Brookfield
BN
|
+$24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.6% |
| 2 | Technology | 16.13% |
| 3 | Healthcare | 10.46% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
S&P Global
SPGI
$124B
| $67.3M | 0.25% |
158,464
-871
| -0.5% | -$377K |
|
52
AB InBev
BUD
$155B
| $67.3M | 0.25% |
1,193,545
-114,286
| -9% | -$7.17M |
|
53
Walt Disney
DIS
$161B
| $65M | 0.24% |
384,106
+18,918
| +5% | +$3.37M |
|
54
Enbridge
ENB
$123B
| $63.8M | 0.24% |
1,603,029
-19,453
| -1% | -$767K |
|
55
Service Corp International
SCI
$10.9B
| $61.8M | 0.23% |
1,025,297
-54,744
| -5% | -$3.33M |
|
|
LSXMK
56
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $57.2M | 0.21% |
1,555,278
-322,432
| -17% | -$11.8M |
|
57
Citigroup
C
$221B
| $55.5M | 0.2% |
790,601
+19,883
| +3% | +$1.39M |
|
|
58
Enanta Pharmaceuticals
ENTA
$377M
| $55.1M | 0.2% |
969,736
+936,536
| +2,821% | +$46.3M |
|
59
Entegris
ENTG
$20.6B
| $54.2M | 0.2% |
430,862
-2,450
| -0.6% | -$295K |
|
60
Moody's
MCO
$82.5B
| $54M | 0.2% |
152,201
-172
| -0.1% | -$64.8K |
|
61
US Bancorp
USB
$98.7B
| $53.3M | 0.2% |
897,060
-6,685
| -0.7% | -$381K |
|
62
Stryker
SYK
$122B
| $50.4M | 0.19% |
191,024
-145
| -0.1% | -$38.8K |
|
63
Canadian Natural Resources
CNQ
$98B
| $49M | 0.18% |
2,740,966
-91,225
| -3% | -$1.5M |
|
64
ZTO Express
ZTO
$18.3B
| $48.5M | 0.18% |
1,581,803
| – | – |
|
65
Pfizer
PFE
$143B
| $47.5M | 0.17% |
1,103,734
-11,383
| -1% | -$504K |
|
66
Liberty Broadband Class C
LBRDK
$4.26B
| $45.1M | 0.17% |
261,089
-2,660
| -1% | -$479K |
|
67
IQVIA
IQV
$34.6B
| $44.8M | 0.17% |
187,012
+9,898
| +6% | +$2.5M |
|
68
Procter & Gamble
PG
$342B
| $41.7M | 0.15% |
298,501
-6,239
| -2% | -$884K |
|
69
JPMorgan Chase
JPM
$930B
| $40.5M | 0.15% |
247,447
+1,034
| +0.4% | +$162K |
|
70
Boeing
BA
$165B
| $37.9M | 0.14% |
172,444
+2,221
| +1% | +$495K |
|
71
Verizon
VZ
$183B
| $35.9M | 0.13% |
664,558
-27,939
| -4% | -$1.55M |
|
72
Ingredion
INGR
$6.32B
| $35.1M | 0.13% |
393,949
-3,246
| -0.8% | -$286K |
|
73
American Water Works
AWK
$26.2B
| $34.5M | 0.13% |
204,313
-1,106
| -0.5% | -$193K |
|
74
CME Group
CME
$91.9B
| $34.3M | 0.13% |
177,448
-16,460
| -8% | -$3.33M |
|
|
BPMC
75
DELISTED
Blueprint Medicines
BPMC
| $32.7M | 0.12% |
317,731
| – | – |
|
Similar funds
SAM
First Manhattan's Q3 2021 Portfolio in Review
As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
- First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
- First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
- First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
- First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
- First Manhattan opened 132 new positions and closed 93 in Q3 2021.
- First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.
Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.